New selective PAD4 inhibitors binding a calcium-deficient sort of the PAD4 enzyme have validated the important enzymatic function of human and mouse PAD4 in the two histone citrullination and neutrophil extracellular entice development for, to our expertise, the first time. The therapeutic potential of PAD4 inhibitors can now be explored. https://timz110kvg3.ja-blog.com/profile